Drug Policy

Virginia’s proposed cannabis labor peace mandate violates federal law

Testimony by Geoffrey Lawrence

FDA commissioner says ‘Everything should be over the counter.’ Don’t count on big pharma to lead the way

Commentary by Jeffrey A. Singer

U.S. v. Hemani: Federal ban on firearm possession by unlawful drug users violates the Second Amendment

Ohio should regulate kratom-related products for adult use instead of pursuing overly restrictive bans

Testimony by Madison Carlino

New Hampshire could expand access to psilocybin

Testimony by Madison Carlino and Kaitlyn Boecker

Cannabusiness lawsuit highlights need for Congress to clarify federal treatment of marijuana

Commentary by Geoffrey Lawrence

What is 7-OH and why did the FDA seize this potentially life-saving substance?

Commentary by Geoffrey Lawrence

Ohio’s reckless kratom ban could create new public safety concerns and grow the illegal market 

Commentary by Michelle Minton

Psychedelics Policy Newsletter: New real-world psilocybin study, ibogaine educational materials, and more

Psychedelics Policy Newsletter by Gregory Ferenstein